Cargando…

Cohort profile: the clinical ‘Psoriasis in Adolescents’ (PIA) cohort in Denmark

PURPOSE: Psoriasis is a chronic inflammatory skin disease that frequently debuts in childhood and adolescence. We wished to determine environmental and genetic risk factors for the development of psoriasis in children and adolescents, as well as to investigate debut type, trigger factors, course of...

Descripción completa

Detalles Bibliográficos
Autores principales: Blegvad, Christoffer, Andersen, Anne-Marie Nybo, Groot, Jonathan, Zachariae, Claus, Skov, Lone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773347/
https://www.ncbi.nlm.nih.gov/pubmed/31551390
http://dx.doi.org/10.1136/bmjopen-2019-031448
_version_ 1783455884610895872
author Blegvad, Christoffer
Andersen, Anne-Marie Nybo
Groot, Jonathan
Zachariae, Claus
Skov, Lone
author_facet Blegvad, Christoffer
Andersen, Anne-Marie Nybo
Groot, Jonathan
Zachariae, Claus
Skov, Lone
author_sort Blegvad, Christoffer
collection PubMed
description PURPOSE: Psoriasis is a chronic inflammatory skin disease that frequently debuts in childhood and adolescence. We wished to determine environmental and genetic risk factors for the development of psoriasis in children and adolescents, as well as to investigate debut type, trigger factors, course of disease, nature and influence of stress related to both child and family and risk factors for comorbidity. The ‘Psoriasis in Adolescents’ (PIA) cohort will provide data on the relationship between psoriasis and, respectively, genetic disposition, early-life exposures, quality of life and comorbidity. PARTICIPANTS: The PIA cohort is nested in the large general population Danish National Birth Cohort (DNBC). We invited 390 adolescents with psoriasis and corresponding maternally predisposed and non-predisposed controls. Participants underwent an interview and a clinical examination consisting of a skin inspection and physical measurements including blood sampling and microbiological swabs. Additionally, four self-administered questionnaires on physical and mental health were completed. FINDINGS TO DATE: The final PIA cohort consists of 81 adolescents with psoriasis, 110 parentally predisposed and 124 non-predisposed psoriasis-free adolescents. The validity of the maternally reported psoriasis status from the DNBC was found to be low on clinical examination (47.5%). In contrast, the self-reported psoriasis status of the DNBC mothers was clinically confirmed in 80.8% of the cases. FUTURE PLANS: The PIA cohort offers the possibility of assessing the clinical characteristics, course of psoriasis and development of comorbidities in adolescents with clinically confirmed disease from a general population. Comparison with predisposed and non-predisposed controls is possible and genetic analyses are scheduled. We plan to invite the participants for a follow-up in 5–10 years. Furthermore, we plan to include newly diagnosed adolescents with psoriasis from the 18-year DNBC follow-up. All information is linkable on the individual level with data from the DNBC and nationwide registries in Denmark.
format Online
Article
Text
id pubmed-6773347
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-67733472019-10-21 Cohort profile: the clinical ‘Psoriasis in Adolescents’ (PIA) cohort in Denmark Blegvad, Christoffer Andersen, Anne-Marie Nybo Groot, Jonathan Zachariae, Claus Skov, Lone BMJ Open Dermatology PURPOSE: Psoriasis is a chronic inflammatory skin disease that frequently debuts in childhood and adolescence. We wished to determine environmental and genetic risk factors for the development of psoriasis in children and adolescents, as well as to investigate debut type, trigger factors, course of disease, nature and influence of stress related to both child and family and risk factors for comorbidity. The ‘Psoriasis in Adolescents’ (PIA) cohort will provide data on the relationship between psoriasis and, respectively, genetic disposition, early-life exposures, quality of life and comorbidity. PARTICIPANTS: The PIA cohort is nested in the large general population Danish National Birth Cohort (DNBC). We invited 390 adolescents with psoriasis and corresponding maternally predisposed and non-predisposed controls. Participants underwent an interview and a clinical examination consisting of a skin inspection and physical measurements including blood sampling and microbiological swabs. Additionally, four self-administered questionnaires on physical and mental health were completed. FINDINGS TO DATE: The final PIA cohort consists of 81 adolescents with psoriasis, 110 parentally predisposed and 124 non-predisposed psoriasis-free adolescents. The validity of the maternally reported psoriasis status from the DNBC was found to be low on clinical examination (47.5%). In contrast, the self-reported psoriasis status of the DNBC mothers was clinically confirmed in 80.8% of the cases. FUTURE PLANS: The PIA cohort offers the possibility of assessing the clinical characteristics, course of psoriasis and development of comorbidities in adolescents with clinically confirmed disease from a general population. Comparison with predisposed and non-predisposed controls is possible and genetic analyses are scheduled. We plan to invite the participants for a follow-up in 5–10 years. Furthermore, we plan to include newly diagnosed adolescents with psoriasis from the 18-year DNBC follow-up. All information is linkable on the individual level with data from the DNBC and nationwide registries in Denmark. BMJ Publishing Group 2019-09-24 /pmc/articles/PMC6773347/ /pubmed/31551390 http://dx.doi.org/10.1136/bmjopen-2019-031448 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Dermatology
Blegvad, Christoffer
Andersen, Anne-Marie Nybo
Groot, Jonathan
Zachariae, Claus
Skov, Lone
Cohort profile: the clinical ‘Psoriasis in Adolescents’ (PIA) cohort in Denmark
title Cohort profile: the clinical ‘Psoriasis in Adolescents’ (PIA) cohort in Denmark
title_full Cohort profile: the clinical ‘Psoriasis in Adolescents’ (PIA) cohort in Denmark
title_fullStr Cohort profile: the clinical ‘Psoriasis in Adolescents’ (PIA) cohort in Denmark
title_full_unstemmed Cohort profile: the clinical ‘Psoriasis in Adolescents’ (PIA) cohort in Denmark
title_short Cohort profile: the clinical ‘Psoriasis in Adolescents’ (PIA) cohort in Denmark
title_sort cohort profile: the clinical ‘psoriasis in adolescents’ (pia) cohort in denmark
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773347/
https://www.ncbi.nlm.nih.gov/pubmed/31551390
http://dx.doi.org/10.1136/bmjopen-2019-031448
work_keys_str_mv AT blegvadchristoffer cohortprofiletheclinicalpsoriasisinadolescentspiacohortindenmark
AT andersenannemarienybo cohortprofiletheclinicalpsoriasisinadolescentspiacohortindenmark
AT grootjonathan cohortprofiletheclinicalpsoriasisinadolescentspiacohortindenmark
AT zachariaeclaus cohortprofiletheclinicalpsoriasisinadolescentspiacohortindenmark
AT skovlone cohortprofiletheclinicalpsoriasisinadolescentspiacohortindenmark